Sign in

Syncona Portfolio LTD

CIK:0001725042
Investment Adviser
$3B AUM
2 holdings
London, United Kingdom
Founded:2012
10 employees
Latest filing:Jun 30, 2025

Syncona is a life science investor focused on funding companies to turn exceptional science into transformational treatments in various therapeutic areas.

Investment Strategy

Investing in life science businesses and single or multi-asset projects to achieve superior long-term capital appreciation.

Top Buys
A
AUTLAUTOLUS THERAPEUTICS PLC
+$12.1M
I
IPSCCENTURY THERAPEUTICS
+$100.7K
Top Sells
A
AUTLAUTOLUS THERAPEUTICS PLC
+$12.1M
I
IPSCCENTURY THERAPEUTICS
+$100.7K

Top Holdings

A
AUTLAUTOLUS THERAPEUTICS PLC
+98.2%$37.9M
I
IPSCCENTURY THERAPEUTICS
+1.8%$678.1K

Equity Positions (2)

TickerSecurityWeightMarket ValueSharesAvg CostPriceChange (QoQ)
A
AUTL
AUTOLUS THERAPEUTICS PLC98.24%$37.9M16,640,720$3.03$2.28+$12.1M
I
IPSC
CENTURY THERAPEUTICS1.76%$678.1K1,213,056$2.29$0.56+$100.7K

Industry Allocation

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+100.0%